Cp*W(NO)(CH 2 CMe 3 ) 2 ( 1 ) and Cp*W(NO)(CH 2 CMe 3 )(CH 2 C 6 H 5 ) ( 2 ) under moderate conditions (70 °C, 40 h) generate the reactive complexes Cp*W(NO)( CHCMe 3 ) ( A ) and Cp*W(NO)( CHC 6 H 5 ) ( B ), respectively, which activate hydrocarbon solvents via the addition of C−H across the M C bond. The α-deuterated derivative Cp*W(NO)(CD 2 CMe 3 ) 2 ( 1- d 4 ) undergoes intramolecular H/D exchange within the neopentyl ligands, consistent with the formation of σ-neopentane complexes prior to neopentane elimination. The thermolysis of 1 in a 1:1 molar mixture of tetramethylsilane- h 12 and tetramethylsilane- d 12 (70 °C, 40 h) yields an intermolecular KIE of 1.07(4):1. Thermolysis of 1 and 2 in 1:1 benzene/benzene- d 6 yields intermolecular KIEs of 1.03(5):1 and 1.17(19):1, respectively. The KIE values are inconsistent with rate-determining C−H bond addition to the M C linkage and indicate that coordination of the substrate to the metal center is the discriminating factor in alkane and arene intermolecular competitions. The complexes Cp*W(NO)(CH 2 CMe 3 )(C 6 D 5 ) ( 5- d 5 ) and Cp*W(NO)(CH 2 C 6 H 5 )(C 6 D 5 ) ( 6- d 5 ) convert to the respective H/D scrambled products Cp*W(NO)(CHD syn CMe 3 )(C 6 D 4 H 1 ) ( 5 ‘ - d 5 ) and Cp*W(NO)(CHD syn C 6 H 5 )(C 6 D 4 H 1 ) ( 6 ‘ - d 5 ) under thermolytic conditions, consistent with the occurrence of reversible aromatic sp 2 C−H bond cleavage. The results suggest that the previously reported discrimination between the aryl and benzyl products of toluene activation by A and B originates from coordination of toluene to the metal center in two distinct modes. Supporting DFT calculations on the activation of toluene by CpW(NO)( CH 2 ) ( C ) indicate that aromatic sp 2 C−H bond activation proceeds through a π-arene complex, while benzylic sp 3 C−H bond activation proceeds through a η 2 ( C, H ),σ-phenylmethane complex. The principal factor behind the preferential formation of the aryl products appears to be the relative energies of formation of these intermediates.
No takes yet. Share an insight, caveat, or question.
Adams et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: